പ്രസിദ്ധീകരിച്ചത് · Malayalam

China Releases New National Calibration Standard for Urine Meters: What Medical Device Founders Need to Know

China's SAMR has issued a new national metrology technical specification for urine meters, setting three evaluation dimensions for ICU monitoring devices. Here is what foreign founders in medical devices and healthcare need to understand about compliance, product design, and market access.

China Issues New Calibration Standard for ICU Urine Meters

China's State Administration for Market Regulation (SAMR) has published a new national metrology technical specification for urine meters, according to a report by CCTV News. The specification, titled Calibration Specification for Urine Meters, is intended to fill a gap in China's technical capacity for calibrating these devices and to strengthen metrological oversight in critical-care settings.

For foreign founders building or selling medical devices in China, this is a signal about how regulators are treating ICU-adjacent monitoring equipment: not only as clinical tools, but as regulated measurement instruments subject to calibration and traceability requirements. Understanding the substance of the specification early can help you align product design, documentation, and after-sales processes with what Chinese regulators and hospitals will expect.

Why Urine Meters Are Treated as Critical Measurement Devices

According to the source, urine output is a core indicator for assessing a critically ill patient's circulation and kidney function. Urine meters are described as core bedside monitoring equipment in intensive care units (ICUs), continuously collecting and recording patient urine data. Clinicians rely on this data when judging a patient's condition and adjusting treatment plans.

The source emphasizes that inaccurate measurement can easily lead to misjudgment of a patient's condition and directly endanger the safety of critically ill patients. That clinical risk framing is the rationale behind regulating the calibration of these devices rather than treating them as ordinary hospital equipment.

The Three Evaluation Dimensions in the Specification

The specification focuses on three metrological characteristic evaluation dimensions. Foreign founders should read these as the performance areas regulators will scrutinize when assessing whether a urine meter is fit for clinical use.

1. Alarm Function

The first dimension concerns the device's alarm capability. The specification requires that equipment can promptly trigger audible and visual alarms when urine output is too high, too low, or when intermittent urine output exceeds a preset threshold. The purpose is to help medical staff quickly identify abnormal changes in a patient's condition.

For product teams, this means alarm logic, thresholds, and notification behavior are part of the regulated performance envelope, not merely a user-interface feature.

2. Accuracy of Total Urine Output Indication

The second dimension evaluates the measurement performance of a device's cumulative urine volume over a specified period. The aim is to ensure that data remains stable and reliable during long-term continuous monitoring scenarios.

This matters for founders whose devices are marketed for extended ICU use, where drift or instability over time could undermine clinical confidence and regulatory compliance.

3. Accuracy of Intermittent Urine Output Indication

The third dimension evaluates measurement performance for cumulative urine volume within intermittent time periods. It is intended to ensure that the real-time display or output of patient urine data is accurate and traceable, providing a solid and credible data foundation for clinical diagnosis.

Traceability is a recurring theme in Chinese metrology regulation. Founders should expect that documentation supporting measurement accuracy and traceability will matter both at registration and during in-use supervision.

How the Specification Connects Industry, Hospitals, and Regulators

The source states that implementation of the specification will connect three links: industry, medical institutions, and metrology supervision. Each carries practical implications for foreign founders operating in China.

Industry Side: Product Design and Factory Controls

On the industry side, the specification is meant to guide manufacturers to optimize product design against actual clinical working conditions and to strengthen metrological performance control at the factory. In practice, foreign founders should consider whether their design inputs, verification testing, and production quality controls reflect the three evaluation dimensions described above.

Use Side: Periodic Traceability in Hospitals

On the use side, the specification is intended to guide medical institutions to establish periodic traceability mechanisms for urine meters, to reinforce the primary responsibility of medical units, and to manage day-to-day metrological control of equipment in use. For founders, this suggests that hospitals may increasingly ask for calibration and traceability support from suppliers, and that after-sales service models should account for periodic calibration needs.

Regulatory Side: Full-Chain Supervision

On the regulatory side, the specification provides an authoritative technical basis for market regulation departments conducting metrological supervision and inspection of medical equipment. The stated goal is to achieve full-chain metrological supervision of critical-care equipment from production through clinical use.

For foreign founders, the phrase "full-chain" is the operative one: compliance does not end at market entry. It extends into how devices are maintained, calibrated, and supervised once they are in Chinese hospitals.

Practical Takeaways for Foreign Founders

• Treat calibration as part of market access. The specification is a national metrology technical specification, meaning it sits within China's measurement regulatory system alongside device registration and post-market obligations.
• Align product documentation with the three dimensions. Alarm behavior, total volume accuracy, and intermittent volume accuracy should be addressed in technical files, test reports, and user manuals.
• Plan for in-use traceability. Hospitals are expected to establish periodic traceability mechanisms, so suppliers should be prepared to support calibration intervals and documentation.
• Design for real ICU conditions. The specification explicitly calls for manufacturers to optimize design against actual clinical working conditions, which is a useful prompt for design validation in Chinese hospital settings.
• Engage local metrology expertise early. Because the specification is technical and calibration-focused, working with qualified local testing and calibration partners can reduce friction during registration and hospital adoption.

What This Means for Market Entry Strategy

The publication of this specification reflects a broader pattern in China's medical device oversight: clinical risk, measurement accuracy, and traceability are being addressed through technical standards that apply across the product lifecycle. Foreign founders should not assume that a device approved in another jurisdiction will automatically satisfy Chinese metrology expectations for ICU monitoring equipment.

Instead, a practical approach is to map the three evaluation dimensions against your current design and quality system, identify documentation gaps, and build a calibration and service plan that supports hospitals' periodic traceability obligations. This is particularly relevant for startups without an established China service network, where calibration support can become a differentiator in hospital procurement conversations.

The source does not specify an implementation date, transitional arrangements, or detailed test methods beyond the three evaluation dimensions, so founders should monitor further guidance from SAMR and local market regulation bureaus as the specification is applied.

Next Steps for Founders

Foreign founders evaluating China market entry for urine meters or related critical-care monitoring devices can begin by reviewing their technical files against the three evaluation dimensions, assessing calibration support options, and planning for post-market traceability requirements. Early preparation can reduce delays when engaging with registration and hospital qualification processes.

Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.